136 related articles for article (PubMed ID: 35417940)
1. Factors associated with left ventricular hypertrophy in children with sickle cell disease: results from the DISPLACE study.
Galadanci NA; Johnson W; Carson A; Hellemann G; Howard V; Kanter J
Haematologica; 2022 Oct; 107(10):2466-2473. PubMed ID: 35417940
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery dilation and left ventricular hypertrophy do not predict morbidity in children with sickle cell disease.
Johnson MC; Johnikin MJ; Euteneuer JC; DeBaun MR; Hildebolt C
Pediatr Blood Cancer; 2015 Jan; 62(1):115-9. PubMed ID: 25264310
[TBL] [Abstract][Full Text] [Related]
4. Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort.
Galadanci NA; Sohail M; Akinyelure OP; Kanter J; Ojesina AI
J Pediatr Hematol Oncol; 2022 Jul; 44(5):249-254. PubMed ID: 34486556
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular geometry and electrocardiographic criteria in assessing left ventricular hypertrophy in sickle cell anemia patients.
Oni OO; Adebiyi AA; Aje A; Akingbola TS
J Natl Med Assoc; 2022 Oct; 114(5):504-511. PubMed ID: 35803775
[TBL] [Abstract][Full Text] [Related]
7. Change in waist circumference over 2 years and the odds of left ventricular hypertrophy among Chinese children.
Wang H; Zhao M; Magnussen CG; Xi B
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2484-2489. PubMed ID: 34088584
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea can be used in children with sickle cell disease and cerebral vasculopathy for the prevention of chronic complications? A meta-analysis.
Núñez RM; Figueroa CAP; García-Perdomo HA
J Child Health Care; 2020 Mar; 24(1):64-77. PubMed ID: 30606035
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia.
Oni OO; Odeyemi AO; Olasinde YT; Odeyemi AO; Olufemi-Aworinde KJ; Abolarin AT; Ala OA
Am J Cardiol; 2023 Sep; 203():175-183. PubMed ID: 37499597
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal effect of disease-modifying therapy on left ventricular diastolic function in children with sickle cell anemia.
Rai P; Okhomina VI; Kang G; Martinez HR; Hankins JS; Joshi V
Am J Hematol; 2023 Jun; 98(6):838-847. PubMed ID: 36890729
[TBL] [Abstract][Full Text] [Related]
12. Obesity, hypertension, and tobacco use associated with left ventricular remodeling and hypertrophy in South African women: Birth to Twenty Plus Cohort.
Kolkenbeck-Ruh A; Soepnel LM; Crouch SH; Naidoo S; Smith W; Norris SA; Davies J; Ware LJ
BMC Cardiovasc Disord; 2022 Sep; 22(1):403. PubMed ID: 36085014
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China.
Wang H; Sun Y; Li Z; Guo X; Chen S; Ye N; Tian Y; Zhang L
BMC Cardiovasc Disord; 2018 Apr; 18(1):62. PubMed ID: 29631555
[TBL] [Abstract][Full Text] [Related]
14. Relationship of a new anthropometric index with left ventricular hypertrophy in hypertensive patients among the Han Chinese.
Cai S; Dong J; Cheng B; Zhang A; Sun J; Li M; Su Y; Bao Q; Zhu P; Wang S
BMC Cardiovasc Disord; 2022 Jan; 22(1):16. PubMed ID: 35081909
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 18 as a new inflammatory mediator in left ventricular hypertrophy in children with end-stage renal disease.
Badawy A; Nigm DA; Ezzat GM; Gamal Y
Saudi J Kidney Dis Transpl; 2020; 31(6):1206-1216. PubMed ID: 33565432
[TBL] [Abstract][Full Text] [Related]
16. Sex difference in the prevalence of left ventricular hypertrophy in dialysis patients.
Cheng LT; Gao YL; Tian JP; Gu Y; Zhang L; Bi SH; Tang W; Lindholm B; Wang T
Am J Nephrol; 2009; 29(5):398-405. PubMed ID: 18997455
[TBL] [Abstract][Full Text] [Related]
17. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
Kim JY; Lee Y; Kang HG; Ha IS; Cheong HI; Choi HJ; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS; Cho H
BMC Nephrol; 2020 Dec; 21(1):533. PubMed ID: 33297989
[TBL] [Abstract][Full Text] [Related]
18. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
19. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
20. Treatment Options for Sickle Cell Disease.
Meier ER
Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
